MatrixCare will be divested for $490 million in an all-cash deal, sharpening focus on core growth areas and enabling capital reallocation. The transaction is expected to close in Q1 FY27, with proceeds used for shareholder returns and general purposes.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.